These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 2432642)
1. [Chemotherapy and immunoprophylaxis of HIV infection]. Vogt M; Schooley RT; Hirsch MS Schweiz Rundsch Med Prax; 1986 Nov; 75(48):1471-5. PubMed ID: 2432642 [No Abstract] [Full Text] [Related]
3. Progress in the development of antiviral therapy for HTLV-III-associated diseases. Yarchoan R; Broder S Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232 [No Abstract] [Full Text] [Related]
5. Antiretroviral therapy and immunologic reconstitution in AIDS. Fauci AS; Lane HC Ann Inst Pasteur Immunol; 1987; 138(2):261-8. PubMed ID: 2955796 [No Abstract] [Full Text] [Related]
6. Antiviral drugs for AIDS. Current status and future prospects. Sandström E Drugs; 1986 Jun; 31(6):463-6. PubMed ID: 2942386 [No Abstract] [Full Text] [Related]
7. Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS). De Clercq E J Med Chem; 1986 Sep; 29(9):1561-9. PubMed ID: 2427720 [No Abstract] [Full Text] [Related]
8. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease. Matthews SJ; Cersosimo RJ; Spivack ML Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897 [TBL] [Abstract][Full Text] [Related]
9. Progress in antiviral drug and vaccine development assessed at international AIDS conference. Miller JL Clin Pharm; 1987 Aug; 6(8):592,595-6. PubMed ID: 2826072 [No Abstract] [Full Text] [Related]
10. [Therapy and immunoprophylaxis of HIV infection]. Vogt M; Täuber M Ther Umsch; 1988 Sep; 45(9):611-8. PubMed ID: 3187915 [No Abstract] [Full Text] [Related]
11. Prospects of therapy for infections with human T-lymphotropic virus type III. Hirsch MS; Kaplan JC Ann Intern Med; 1985 Nov; 103(5):750-5. PubMed ID: 2413793 [TBL] [Abstract][Full Text] [Related]
12. Strategies for antiviral therapy in AIDS. Mitsuya H; Broder S Nature; 1987 Feb 26-Mar 4; 325(6107):773-8. PubMed ID: 2434858 [TBL] [Abstract][Full Text] [Related]
14. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921 [No Abstract] [Full Text] [Related]
15. Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. Sandström EG; Kaplan JC Drugs; 1987 Sep; 34(3):372-90. PubMed ID: 2824170 [TBL] [Abstract][Full Text] [Related]
16. Antiviral drug development for the treatment of human immunodeficiency virus infections. An overview. Hirsch MS Am J Med; 1988 Aug; 85(2A):182-5. PubMed ID: 3044083 [TBL] [Abstract][Full Text] [Related]
17. Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study. Eeftinck Schattenkerk JK; Danner SA; Lange JM; Paul DA; van Boxtel CJ; Miedema F; Schellekens PT; Goudsmit J Arch Intern Med; 1988 Jan; 148(1):209-11. PubMed ID: 2447847 [TBL] [Abstract][Full Text] [Related]
18. [Azidothymidine and HIV infection]. Offerhaus L Ned Tijdschr Geneeskd; 1987 May; 131(22):934-6. PubMed ID: 3037393 [No Abstract] [Full Text] [Related]
19. [Experimental chemotherapy of AIDS]. Rada B Cas Lek Cesk; 1988 May; 127(22):677-83. PubMed ID: 3293790 [No Abstract] [Full Text] [Related]
20. Declining levels of HIV P24 antigen in serum during treatment with foscarnet. Bergdahl S; Sönnerborg A; Larsson A; Strannegard O Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890 [No Abstract] [Full Text] [Related] [Next] [New Search]